This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Kabushiki Kaisha Yakult Honsha, Keio University. Active years: 2017-2019.
Company Filing History:
2 out of 215 
2 out of 360 
Years Active: 2017-2019
Title: Innovations of Junya Tsuzaki in Cancer Therapeutics.
Introduction
Junya Tsuzaki is a notable inventor based in Shinjuku-ku, Japan. He has made significant contributions to the field of cancer therapeutics, particularly through his innovative patents. With a total of two patents to his name, Tsuzaki's work focuses on improving the effectiveness of anti-cancer agents.
Latest Patents
One of Tsuzaki's latest patents is a combined anticancer drug sensitivity-determining marker. This marker is designed to determine whether a patient has a therapeutic response to an anti-cancer agent. The anti-cancer agent sensitivity determination marker includes oxaliplatin or a salt thereof and fluorouracil or a salt thereof. It contains one or more substances selected from various metabolic pathways, including amino-acid metabolism, nucleic-acid metabolism, and the TCA cycle, among others. This innovative approach aims to enhance the efficacy of cancer treatments by tailoring them to individual patient responses.
Career Highlights
Throughout his career, Junya Tsuzaki has worked with esteemed institutions such as Keio University and Yakult Honsha Co., Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field of cancer research and therapeutics.
Collaborations
Some of Tsuzaki's notable coworkers include Yusuke Tanigawara and Akito Nishimuta. Their collaborative efforts have contributed to the advancement of cancer treatment methodologies.
Conclusion
Junya Tsuzaki's innovative work in developing anticancer drug sensitivity markers represents a significant advancement in personalized cancer therapy. His contributions continue to influence the field and offer hope for improved treatment outcomes for cancer patients.